Copper and Molybdenum Balance in Participants With Wilson Disease Treated With ALXN1840

NCT04573309 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Wilson Disease

Interventions

DRUG: ALXN1840

Sponsor

Alexion Pharmaceuticals, Inc.